Transportation Healthcare Sector

Tilray Brands

Market Cap: US$449.5m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

kneat.com

Market Cap: CA$616.9m

Designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific.

Clarity Pharmaceuticals

Market Cap: AU$694.1m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

Altimmune

Market Cap: US$445.3m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

Oruka Therapeutics

Market Cap: US$443.7m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Allergy Therapeutics

Market Cap: UK£328.9m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

Orthofix Medical

Market Cap: US$442.7m

Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.

PureTech Health

Market Cap: UK£328.1m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Sonida Senior Living

Market Cap: US$441.2m

Owns and operates senior housing communities in the United States.

Cross Country Healthcare

Market Cap: US$440.3m

Provides talent management services for healthcare clients in the United States.

Claritev

Market Cap: US$438.2m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

SIGA Technologies

Market Cap: US$435.1m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Bioventus

Market Cap: US$433.3m

A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.

Septerna

Market Cap: US$433.1m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Senseonics Holdings

Market Cap: US$429.2m

A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

REGENXBIO

Market Cap: US$428.4m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Faron Pharmaceuticals Oy

Market Cap: UK£317.6m

Operates as a clinical stage drug discovery and development company.

Amylyx Pharmaceuticals

Market Cap: US$427.0m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Verastem

Market Cap: US$427.0m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

ORIC Pharmaceuticals

Market Cap: US$424.4m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Tourmaline Bio

Market Cap: US$424.1m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

CytoDyn

Market Cap: US$421.2m

A clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications.

Development Technologies

Market Cap: US$420.0m

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.

Paragon Care

Market Cap: AU$653.8m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.

MBX Biosciences

Market Cap: US$418.5m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Zenas BioPharma

Market Cap: US$418.3m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Tectonic Therapeutic

Market Cap: US$418.3m

A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).

Surmodics

Market Cap: US$417.5m

Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.

Zhengye Biotechnology Holding

Market Cap: US$417.0m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

AngioDynamics

Market Cap: US$416.6m

A medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.

Knight Therapeutics

Market Cap: CA$573.9m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Personalis

Market Cap: US$415.1m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Standard BioTools

Market Cap: US$414.0m

Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

Benitec Biopharma

Market Cap: US$413.2m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Vitalhub

Market Cap: CA$569.0m

Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

MeiraGTx Holdings

Market Cap: US$409.9m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.